NALLY MICHAEL (Chief Executive Officer) reported 1 transaction at GENERATE BIOMEDICINES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/2/2026ACC: 0001193125-26-085883
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+1.35M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
2.35M acquired · 1M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+658.33K
Price / share
—
Trade value
—
% of position
100.0%
3/2/2026
658.33K→1.32M
Total
Net shares
+658.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/2/2026 | C · Conversion | +658.33K | — | — | 100.0% | 658.33K | 1.32M |
| Total | +658.33K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
844.60K shares
Shares
+844.60K
Strike price
16
Held after
844.60K
Exercisable
—
2/26/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
844.60K shares
Shares
+844.60K
Strike price
16
Held after
844.60K
Exercisable
—
2/26/2026
Series A Preferred Stock
Indirect
Converts to
Common Stock
658.33K shares
Shares
−1M
Strike price
Held after
0.00
Exercisable
—
3/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock844.60K shares | 2/26/2026 | A · Award | +844.60K | 16 | — | 844.60K |
| Stock Option (Right to Buy) Direct | Common Stock844.60K shares | 2/26/2026 | A · Award | +844.60K | 16 | — | 844.60K |
| Series A Preferred Stock Indirect | Common Stock658.33K shares | 3/2/2026 | C · Conversion | −1M | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned552.71K
Common Stock
IndirectShares owned999.79K
Total
552.71K direct·999.79K indirect1.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 552.71K | Direct |
| Common Stock | 999.79K | Indirect |
| Total | 1.55M | 552.71K direct·999.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported